Your browser doesn't support javascript.
loading
SalmoFree® Phage Additive Proves Its Safety for Laying Hens.
Hernández Villamizar, Santiago; Bonilla, Juliana Arias; Jaramillo, Álvaro Hugo; Piñeros, Ricardo; Ripoll, Antonio; Fonseca, Laura; Riveros, Karen; Vives, Martha J; Barato, Paola; Clavijo, Viviana.
Affiliation
  • Hernández Villamizar S; Ciencia y Tecnología de Fagos Sciphage SAS, Mosquera, Colombia.
  • Bonilla JA; Ciencia y Tecnología de Fagos Sciphage SAS, Mosquera, Colombia.
  • Jaramillo ÁH; Departamento de Ciencias Biológicas, Universidad de los Andes, Bogotá, Colombia.
  • Piñeros R; Centro de Biotecnología Agropecuario SENA, Mosquera, Colombia.
  • Ripoll A; Corporación Patología Veterinaria CORPAVET, Bogotá, Colombia.
  • Fonseca L; Departamento de Ciencias Biológicas, Universidad de los Andes, Bogotá, Colombia.
  • Riveros K; Corporación Patología Veterinaria CORPAVET, Bogotá, Colombia.
  • Vives MJ; Ciencia y Tecnología de Fagos Sciphage SAS, Mosquera, Colombia.
  • Barato P; Departamento de Ciencias Biológicas, Universidad de los Andes, Bogotá, Colombia.
  • Clavijo V; Corporación Patología Veterinaria CORPAVET, Bogotá, Colombia.
Phage (New Rochelle) ; 5(3): 143-152, 2024 Sep.
Article in En | MEDLINE | ID: mdl-39372358
ABSTRACT

Background:

The avian pathogen Salmonella Gallinarum causes avian typhosis in laying hens, leading to high mortality rates among adult birds, which poses a significant problem in the poultry industry. Various products, such as vaccines, antibiotics, probiotics, and disinfectants, are commonly used to prevent and control the disease on farms. An alternative to these products is the use of bacteriophages, which may effectively prevent the colonization of S. Gallinarum. Materials and

Methods:

This study evaluated the safety of SalmoFree®, a bacteriophage cocktail, administered to 276 laying hens from the first week of age until the 28th week. The hens were divided into two groups a control group (138 birds) and a treatment group (138 birds). Over the 28-week period, eight doses of SalmoFree® (∼1010 UFP per bird) were administered via drinking water in a controlled environment.

Results:

The results indicate that the consumption of SalmoFree® has no adverse effects on bird health or zootechnical parameters. Additionally, there is a trend toward improving weight homogeneity (up to 19%), feed conversion (up to 68%), and egg weight (up to 2.7%). The detection of phages by PCR in cloacal swabs suggests that they persist in birds for 2 to 8 weeks post-ingestion. Furthermore, phages were detected in organs and eggshells, indicating that they provide protection beyond the gut.

Conclusion:

The study demonstrates that SalmoFree® is safe for use in laying hens and may offer additional benefits, such as improved zootechnical parameters and extended protection against S. Gallinarum through the persistence of bacteriophages in the birds.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Phage (New Rochelle) Year: 2024 Document type: Article Affiliation country: Colombia Country of publication: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Phage (New Rochelle) Year: 2024 Document type: Article Affiliation country: Colombia Country of publication: United States